TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A 10-Week Pilot Study of Varenicline (Champix) Versus Placebo for Smoking Cessation/Reduction in Patients With Bipolar Disorder
Brief Summary: Bipolar Disorder is a chronic relapsing mental disorder characterized by periods of elevated, expansive and irritable mood, often alternating with periods of significant clinical depression. People with Bipolar Disorder are typically heavy smokers who have difficulty quitting, and this is associated with significant tobacco-related medical illness and death.

The proposed study will be a double-blind, placebo-controlled 10-week clinical trial of the safety and efficacy of varenicline (Champix™) in thirty subjects with Bipolar I Disorder. This medication is the latest first-line pharmacotherapy for smoking cessation and has been shown to be efficacious for smoking cessation, but has not yet been systematically studied in persons with Bipolar Disorder.


Options:
A: Arm Label: Varenicline; Type: EXPERIMENTAL; Interventions: Drug: Varenicline | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Varenicline; Assigned to Arm(s): Varenicline | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Varenicline Tartrate; Type: ACTIVE_COMPARATOR; Interventions: Drug: Varenicline Tartrate | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Varenicline Tartrate; Assigned to Arm(s): Varenicline Tartrate | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Selegiline + nicotine replacement therapy | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo + nicotine replacement therapy | Intervention Type: DRUG; Name: Selegiline + nicotine replacement therapy; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: placebo + nicotine replacement therapy; Assigned to Arm(s): 2
D: Intervention Type: DRUG; Name: varenicline; Assigned to Arm(s): N/A

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A 10-Week Pilot Study of Varenicline (Champix) Versus Placebo for Smoking Cessation/Reduction in Patients With Bipolar Disorder
Brief Summary: Bipolar Disorder is a chronic relapsing mental disorder characterized by periods of elevated, expansive and irritable mood, often alternating with periods of significant clinical depression. People with Bipolar Disorder are typically heavy smokers who have difficulty quitting, and this is associated with significant tobacco-related medical illness and death.

The proposed study will be a double-blind, placebo-controlled 10-week clinical trial of the safety and efficacy of varenicline (Champix™) in thirty subjects with Bipolar I Disorder. This medication is the latest first-line pharmacotherapy for smoking cessation and has been shown to be efficacious for smoking cessation, but has not yet been systematically studied in persons with Bipolar Disorder.


Options:
A: Arm Label: Brief Treatment; Type: ACTIVE_COMPARATOR; Interventions: Drug: Nicotine polacrilex, Bupropion | Arm Label: Extended NRT; Type: EXPERIMENTAL; Interventions: Drug: Nicotine polacrilex, Bupropion | Arm Label: Tailored/No Extended NRT; Type: EXPERIMENTAL; Interventions: Drug: Nicotine polacrilex, Bupropion | Arm Label: Extended Tailored Counseling + NRT; Type: EXPERIMENTAL; Interventions: Drug: Nicotine polacrilex, Bupropion | Intervention Type: DRUG; Name: Nicotine polacrilex, Bupropion; Assigned to Arm(s): Brief Treatment, Extended NRT, Extended Tailored Counseling + NRT, Tailored/No Extended NRT
B: Intervention Type: DRUG; Name: varenicline; Assigned to Arm(s): N/A
C: Intervention Type: DRUG; Name: Varenicline tartrate; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): N/A
D: Intervention Type: DRUG; Name: varenicline (CP-526,555); Assigned to Arm(s): N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: An Open-Label Study of Dronabinol, a Cannabinoid Agonist, for Obsessive Compulsive Disorder and the Obsessive-Compulsive Spectrum Disorders Trichotillomania and Pathological Skin Picking
Brief Summary: The goal of the proposed study is to evaluate the efficacy and safety of dronabinol in individuals with obsessive-compulsive disorder (OCD) or the obsessive-compulsive spectrum disorders, trichotillomania (TTM) or pathological skin picking (PSP). Fifteen patients with OCD, TTM, or PSP will receive 12 weeks of open-label treatment with dronabinol. The hypothesis to be tested is that dronabinol will be effective and well tolerated in patients with these disorders. The proposed study will provide needed data on the treatment of a disabling disorder that currently lacks a clearly effective treatment.


Options:
A: Intervention Type: DRUG; Name: Olanzapine; Assigned to Arm(s): N/A
B: Arm Label: N-Acetyl Cysteine; Type: ACTIVE_COMPARATOR; Interventions: Drug: N-Acetyl Cysteine | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: N-Acetyl Cysteine; Assigned to Arm(s): N-Acetyl Cysteine
C: Intervention Type: DRUG; Name: Methylphenidate; Assigned to Arm(s): N/A
D: Arm Label: Dronabinol; Type: EXPERIMENTAL; Interventions: Drug: Dronabinol | Intervention Type: DRUG; Name: Dronabinol; Assigned to Arm(s): Dronabinol

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Formula With Modified Content of Protein and Improved Fatty Acids and Their Impact on Infant Growth and Health
Brief Summary: In this study, the suitability of an infant formula with a modified content of protein and fatty acid pattern (LC-PUFA) for healthy term infants will be investigated.

Primary hypothesis to be tested is: an infant formula with a modified protein content is non inferior compared to a standard infant formula in respect to the growth of healthy term infants.


Options:
A: Intervention Type: PROCEDURE; Name: Supplement of fatty acid (DHA and AA); Assigned to Arm(s): N/A
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Other: DHA and ARA | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Other: DHA and ARA | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Other: DHA and ARA | Arm Label: 4; Type: OTHER; Interventions: Other: Control | Intervention Type: OTHER; Name: DHA and ARA; Assigned to Arm(s): 1, 2, 3 | Intervention Type: OTHER; Name: Control; Assigned to Arm(s): 4
C: Arm Label: standard infant formula; Type: ACTIVE_COMPARATOR; Interventions: Other: standard infant formula | Arm Label: modified infant formula; Type: EXPERIMENTAL; Interventions: Other: modified infant formula | Arm Label: breast milk; Type: OTHER; Interventions: Other: breast milk | Intervention Type: OTHER; Name: standard infant formula; Assigned to Arm(s): standard infant formula | Intervention Type: OTHER; Name: modified infant formula; Assigned to Arm(s): modified infant formula | Intervention Type: OTHER; Name: breast milk; Assigned to Arm(s): breast milk
D: Arm Label: Commercially available infant formula A; Type: EXPERIMENTAL; Interventions: Other: Infant Formula milk based | Arm Label: Commercially available infant formula B; Type: ACTIVE_COMPARATOR; Interventions: Other: Infant formula milk based | Intervention Type: OTHER; Name: Infant Formula milk based; Assigned to Arm(s): Commercially available infant formula A | Intervention Type: OTHER; Name: Infant formula milk based; Assigned to Arm(s): Commercially available infant formula B

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Formula With Modified Content of Protein and Improved Fatty Acids and Their Impact on Infant Growth and Health
Brief Summary: In this study, the suitability of an infant formula with a modified content of protein and fatty acid pattern (LC-PUFA) for healthy term infants will be investigated.

Primary hypothesis to be tested is: an infant formula with a modified protein content is non inferior compared to a standard infant formula in respect to the growth of healthy term infants.


Options:
A: Arm Label: standard infant formula; Type: ACTIVE_COMPARATOR; Interventions: Other: standard infant formula | Arm Label: modified infant formula; Type: EXPERIMENTAL; Interventions: Other: modified infant formula | Arm Label: breast milk; Type: OTHER; Interventions: Other: breast milk | Intervention Type: OTHER; Name: standard infant formula; Assigned to Arm(s): standard infant formula | Intervention Type: OTHER; Name: modified infant formula; Assigned to Arm(s): modified infant formula | Intervention Type: OTHER; Name: breast milk; Assigned to Arm(s): breast milk
B: Arm Label: DHA capsules; Type: EXPERIMENTAL; Interventions: Drug: DHA | Arm Label: Placebo capsules; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo capsule | Intervention Type: DRUG; Name: DHA; Assigned to Arm(s): DHA capsules | Intervention Type: OTHER; Name: Placebo capsule; Assigned to Arm(s): Placebo capsules
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Other: DHA and ARA | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Other: DHA and ARA | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Other: DHA and ARA | Arm Label: 4; Type: OTHER; Interventions: Other: Control | Intervention Type: OTHER; Name: DHA and ARA; Assigned to Arm(s): 1, 2, 3 | Intervention Type: OTHER; Name: Control; Assigned to Arm(s): 4
D: Arm Label: 1; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Docosahexaenoic acid (DHA) | Intervention Type: DIETARY_SUPPLEMENT; Name: Docosahexaenoic acid (DHA); Assigned to Arm(s): 2

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Deep Brain Stimulation of the Nucleus Basalis Meynert to Treat Cognitive Deficits in Light to Moderate Alzheimer's Disease
Brief Summary: In the study at hand, six patients with light to moderate Alzheimer's disease will be enrolled and implanted with bilateral electrodes in the nucleus basalis Meynert.


Options:
A: Arm Label: DBS Off first; Type: EXPERIMENTAL; Interventions: Procedure: Bilateral GPi Deep Brain Stimulation | Arm Label: DBS On First; Type: EXPERIMENTAL; Interventions: Procedure: Bilateral GPi Deep Brain Stimulation | Intervention Type: PROCEDURE; Name: Bilateral GPi Deep Brain Stimulation; Assigned to Arm(s): DBS Off first, DBS On First
B: Arm Label: Placebo; Type: SHAM_COMPARATOR; Interventions: Other: Deep brain stimulation | Arm Label: Deep Brain Stimulation; Type: ACTIVE_COMPARATOR; Interventions: Other: Deep brain stimulation | Intervention Type: OTHER; Name: Deep brain stimulation; Assigned to Arm(s): Deep Brain Stimulation, Placebo
C: Arm Label: Deep Brain Stimulation; Type: ACTIVE_COMPARATOR; Interventions: Other: Deep brain stimulation | Arm Label: Placebo; Type: SHAM_COMPARATOR; Interventions: Other: Placebo | Intervention Type: OTHER; Name: Deep brain stimulation; Assigned to Arm(s): Deep Brain Stimulation | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Continuous Deep Brain Stimulation (DBS); Type: EXPERIMENTAL; Interventions: Device: Continuous DBS | Arm Label: Responsive Brain Stimulation (RBS Setting); Type: EXPERIMENTAL; Interventions: Device: Responsive Brain Stimulation (RBS Setting) | Intervention Type: DEVICE; Name: Continuous DBS; Assigned to Arm(s): Continuous Deep Brain Stimulation (DBS) | Intervention Type: DEVICE; Name: Responsive Brain Stimulation (RBS Setting); Assigned to Arm(s): Responsive Brain Stimulation (RBS Setting)

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase II Placebo Controlled Randomised Study of Aramchol on Liver Triglyceride in Patients With Steatosis Due to NAFLD or NASH
Brief Summary: Primary purpose: Compare the changes in liver triglycerides concentration in the Aramchol versus the placebo arm following three month treatment.

Secondary purpose: Comparing liver enzymes, markers of endothelial dysfunction, insulin resistance, SCD1 activity and cholesterol synthesis and lipid levels, between the Aramchol and the placebo arms.


Options:
A: Arm Label: high dose; Type: EXPERIMENTAL; Interventions: Drug: Aramchol | Arm Label: low dose; Type: EXPERIMENTAL; Interventions: Drug: Aramchol | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Aramchol; Assigned to Arm(s): low dose | Intervention Type: DRUG; Name: Aramchol; Assigned to Arm(s): high dose | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Ezetimibe; Type: EXPERIMENTAL; Interventions: Drug: Ezetimibe | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Ezetimibe | Intervention Type: DRUG; Name: Ezetimibe; Assigned to Arm(s): Ezetimibe, Placebo
C: Arm Label: Polypill; Type: EXPERIMENTAL; Interventions: Drug: Polypill | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Polypill; Assigned to Arm(s): Polypill
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: RO5093151 | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: RO5093151; Assigned to Arm(s): 1

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomised Trial of Ophira™ Minisling System and Unitape™ for the Treatment of Stress Urinary Incontinence in Women
Brief Summary: A study to compare efficacy in surgical treatment for SUI (Stress Urinary Incontinence), tot with minisling.


Options:
A: Arm Label: TVT SECURE; Type: ACTIVE_COMPARATOR; Interventions: Procedure: transvaginal obturator tape | Arm Label: TVT O; Type: ACTIVE_COMPARATOR; Interventions: Procedure: transvaginal obturator tape | Intervention Type: PROCEDURE; Name: transvaginal obturator tape; Assigned to Arm(s): TVT O, TVT SECURE
B: Arm Label: Single incision mini-sling; Type: EXPERIMENTAL; Interventions: Device: Ophira | Arm Label: Transobturator sling; Type: ACTIVE_COMPARATOR; Interventions: Device: Transobturator sling | Intervention Type: DEVICE; Name: Ophira; Assigned to Arm(s): Single incision mini-sling | Intervention Type: DEVICE; Name: Transobturator sling; Assigned to Arm(s): Transobturator sling
C: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Ajust positioning | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Procedure: MiniArc positioning | Arm Label: 3; Type: ACTIVE_COMPARATOR; Interventions: Procedure: TVT secur system positioning | Arm Label: 4; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Tension free vaginal ttape | Intervention Type: PROCEDURE; Name: MiniArc positioning; Assigned to Arm(s): 2 | Intervention Type: PROCEDURE; Name: TVT secur system positioning; Assigned to Arm(s): 3 | Intervention Type: PROCEDURE; Name: Ajust positioning; Assigned to Arm(s): 1 | Intervention Type: PROCEDURE; Name: Tension free vaginal ttape; Assigned to Arm(s): 4
D: Arm Label: Mini-sling; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Mini-sling | Arm Label: Transobturator; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Transobturator | Intervention Type: PROCEDURE; Name: Mini-sling; Assigned to Arm(s): Mini-sling | Intervention Type: PROCEDURE; Name: Transobturator; Assigned to Arm(s): Transobturator

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomised Comparison of Postoperative Pain and Recovery Between Single Incision Laparoscopic Cholecystectomy Using One Port and Standard Laparoscopic Cholecystectomy Using Four Ports
Brief Summary: Laparoscopic cholecystectomy has been established as the treatment of choice for symptomatic gallstone disease. The main advantages of laparoscopic surgery are the cosmetic result, reduced postoperative pain, shorter hospital stay and rapid return to normal activity. Although reduced, however, pain is still substantial and constitutes the main clinical problem after laparoscopic cholecystectomy, especially for planned day case procedures.

Recently, a new technique of laparoscopic cholecystectomy has been developed, in which all instruments are inserted through the same umbilical incision. The single incision laparoscopic surgery (SILS) technique for cholecystectomy has been proved to be feasible and safe by several studies.

The purpose of the study is to compare postoperative pain and operating time, nausea, vomiting, tissue damage, pulmonary function, cosmetic result, quality of life between SILS and standard laparoscopic cholecystectomy.


Options:
A: Arm Label: LESS cholecystectomy; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Cholecystectomy | Arm Label: Standard LAP-CHOLE; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Cholecystectomy | Arm Label: LESS Cholecystectomy not blind; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Cholecystectomy | Intervention Type: PROCEDURE; Name: Cholecystectomy; Assigned to Arm(s): LESS Cholecystectomy not blind, LESS cholecystectomy, Standard LAP-CHOLE
B: Arm Label: 1; Type: OTHER; Interventions: Procedure: SPA cholecystectomy | Arm Label: 2; Type: OTHER; Interventions: Procedure: Laparoscopic cholecystectomy | Intervention Type: PROCEDURE; Name: SPA cholecystectomy; Assigned to Arm(s): 1 | Intervention Type: PROCEDURE; Name: Laparoscopic cholecystectomy; Assigned to Arm(s): 2
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Device: Laparoscopic cholecystectomy surgery | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Device: Laparoscopic cholecystectomy surgery | Intervention Type: DEVICE; Name: Laparoscopic cholecystectomy surgery; Assigned to Arm(s): 1, 2
D: Arm Label: Standard lap chole; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Standard laparoscopic cholecystectomy | Arm Label: Single incision lap chole; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Single incision laparoscopic cholecystectomy | Intervention Type: PROCEDURE; Name: Standard laparoscopic cholecystectomy; Assigned to Arm(s): Standard lap chole | Intervention Type: PROCEDURE; Name: Single incision laparoscopic cholecystectomy; Assigned to Arm(s): Single incision lap chole

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Evaluation of the Safety and Performance of the Zilver® PTX™ Drug-Eluting Stent for Treating De Novo or Restenotic Lesions of the Above-the-knee Femoropopliteal Artery
Brief Summary: The Zilver PTX Registry Study is a prospective, non-randomized, open-label, multicenter single-arm study enrolling patients in Europe, Asia, and North America with de novo or restenotic (including in-stent restenosis) lesions of the above-the-knee femoropopliteal artery (SFA). The primary endpoint of the study is event-free survival (EFS) at 6 months.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Device: Zilver® PTX™ Drug Eluting Vascular Stent | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Angioplasty | Intervention Type: DEVICE; Name: Zilver® PTX™ Drug Eluting Vascular Stent; Assigned to Arm(s): 1 | Intervention Type: PROCEDURE; Name: Angioplasty; Assigned to Arm(s): 2
B: Arm Label: DEB; Type: N/A; Interventions: Device: DEB | Arm Label: conventional PTA; Type: N/A; Interventions: Device: POBA | Intervention Type: DEVICE; Name: DEB; Assigned to Arm(s): DEB | Intervention Type: DEVICE; Name: POBA; Assigned to Arm(s): conventional PTA
C: Arm Label: Stent; Type: EXPERIMENTAL; Interventions: Device: Zilver® PTX™ Stent | Intervention Type: DEVICE; Name: Zilver® PTX™ Stent; Assigned to Arm(s): Stent
D: Arm Label: Drug Eluting Balloon; Type: EXPERIMENTAL; Interventions: Device: IN.PACT Amphirion | Arm Label: Standard PTA; Type: ACTIVE_COMPARATOR; Interventions: Device: Standard PTA | Intervention Type: DEVICE; Name: IN.PACT Amphirion; Assigned to Arm(s): Drug Eluting Balloon | Intervention Type: DEVICE; Name: Standard PTA; Assigned to Arm(s): Standard PTA

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Comparative Study of TVTO™ X TVTS ™ for Treatment of Stress Urinary Incontinence
Brief Summary: This is a prospective, comparative randomized controled trial. The general purposes of this study is to compare the efficacy and safety of TVTO™ and TVTSecur™ as surgical treatment for female urinary stress incontinence.


Options:
A: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Device: tension-free vaginal tape | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Device: TVT-SECUR device | Intervention Type: DEVICE; Name: tension-free vaginal tape; Assigned to Arm(s): 1 | Intervention Type: DEVICE; Name: TVT-SECUR device; Assigned to Arm(s): 2
B: Arm Label: TVT-O; Type: ACTIVE_COMPARATOR; Interventions: Device: TVT-O | Arm Label: TVT-S; Type: ACTIVE_COMPARATOR; Interventions: Device: TVT-S | Intervention Type: DEVICE; Name: TVT-O; Assigned to Arm(s): TVT-O | Intervention Type: DEVICE; Name: TVT-S; Assigned to Arm(s): TVT-S
C: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Ajust positioning | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Procedure: MiniArc positioning | Arm Label: 3; Type: ACTIVE_COMPARATOR; Interventions: Procedure: TVT secur system positioning | Arm Label: 4; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Tension free vaginal ttape | Intervention Type: PROCEDURE; Name: MiniArc positioning; Assigned to Arm(s): 2 | Intervention Type: PROCEDURE; Name: TVT secur system positioning; Assigned to Arm(s): 3 | Intervention Type: PROCEDURE; Name: Ajust positioning; Assigned to Arm(s): 1 | Intervention Type: PROCEDURE; Name: Tension free vaginal ttape; Assigned to Arm(s): 4
D: Arm Label: Ajust; Type: EXPERIMENTAL; Interventions: Device: Ajust sling | Arm Label: Classical transobturator tape; Type: ACTIVE_COMPARATOR; Interventions: Device: Classical transobturator sling | Intervention Type: DEVICE; Name: Ajust sling; Assigned to Arm(s): Ajust | Intervention Type: DEVICE; Name: Classical transobturator sling; Assigned to Arm(s): Classical transobturator tape

Answer: B